These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. Aime S, Fasano M, Bergamasco B, Lopiano L, Valente G. J Neurochem; 1994 Jan; 62(1):369-71. PubMed ID: 8263538 [Abstract] [Full Text] [Related]
12. Iron-binding characteristics of neuromelanin of the human substantia nigra. Double KL, Gerlach M, Schünemann V, Trautwein AX, Zecca L, Gallorini M, Youdim MB, Riederer P, Ben-Shachar D. Biochem Pharmacol; 2003 Aug 01; 66(3):489-94. PubMed ID: 12907248 [Abstract] [Full Text] [Related]
13. The role of transition metals in the pathogenesis of Parkinson's disease. Kienzl E, Puchinger L, Jellinger K, Linert W, Stachelberger H, Jameson RF. J Neurol Sci; 1995 Dec 01; 134 Suppl():69-78. PubMed ID: 8847547 [Abstract] [Full Text] [Related]
14. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. Shima T, Sarna T, Swartz HM, Stroppolo A, Gerbasi R, Zecca L. Free Radic Biol Med; 1997 Dec 01; 23(1):110-9. PubMed ID: 9165303 [Abstract] [Full Text] [Related]
19. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation. Noguchi N, Nishino K, Niki E. Biochem Pharmacol; 2000 May 01; 59(9):1069-76. PubMed ID: 10704936 [Abstract] [Full Text] [Related]